Petição de recurso
#12.2
Recurso: 870250027797 - 7/4/2025
04/15/2025
RPI 2832
Application data
Number
112019016043Type
Filing
Publication
PCT
EP2018052694 The application is under appeal: the INPI has yet to review the decision.
Latest action published by the INPI: 04/15/2025. We update with every new RPI gazette, published weekly.
Applicants
JANSSEN PHARMACEUTICA NV
BE
Inventors
A. A. (pessoa física)
US
A. S. (pessoa física)
BE
J. R. (pessoa física)
ES
K. S. (pessoa física)
BE
P. P. (pessoa física)
BE
Y. L. (pessoa física)
FR
IPC Classification
Priority claims
EP
17209098.7 · 12/20/2017
US
62/455,211 · 02/06/2017
Abstract
A presente invenção refere-se a um método para o tratamento de câncer com erdafitinib.
Publications in the Brazilian Industrial Property Gazette (RPI).
#12.2
Recurso: 870250027797 - 7/4/2025
04/15/2025
RPI 2832
#9.2
02/04/2025
RPI 2822
#7.1
10/22/2024
RPI 2807
#6.23
07/26/2022
RPI 2690
#15.35
10/13/2021
RPI 2649
#1.3
03/31/2020
RPI 2569
#1.1
08/13/2019
RPI 2536
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.